PubMed for id: 79679

Year	Number of Results
1994	1
2002	1
2003	6
2004	1
2005	2
2006	6
2007	2
2008	2
2009	4
2010	8
2011	7
2012	6
2013	11
2014	13
2015	14
2016	20
2017	20
2018	12
2019	12
2020	17
2021	7
2022	10
2023	5
2024	0

1

Diagnostic, clinicopathological features and prognostic value of B7x expression in Chinese women with breast cancer: A meta-analysis.

Su H, Lin X, Huo J, Zhang F. Su H, et al. Asian J Surg. 2023 Nov;46(11):5210-5216. doi: 10.1016/j.asjsur.2023.07.028. Epub 2023 Jul 20. Asian J Surg. 2023. PMID: 37481357 Free article. No abstract available.

2

B7x in cancer immunity and immunotherapy.

Mortezaee K. Mortezaee K. Int Immunopharmacol. 2023 May;118:110133. doi: 10.1016/j.intimp.2023.110133. Epub 2023 Apr 5. Int Immunopharmacol. 2023. PMID: 37028278 Review.

3

The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.

Hwang C, Lee HJ, Na JY, Kim KH, Song YJ, Kim JY, Kim K, Shin DH, Park JY, Kim SY, Lee JH, Choi KU. Hwang C, et al. J Ovarian Res. 2023 Jan 6;16(1):3. doi: 10.1186/s13048-022-01076-z. J Ovarian Res. 2023. PMID: 36609273 Free PMC article.

4

The immunological role of B7-H4 in pregnant women with Sars-Cov2 infection.

Duan L, Reisch B, Mach P, Kimmig R, Gellhaus A, Iannaccone A. Duan L, et al. Am J Reprod Immunol. 2022 Dec;88(6):e13626. doi: 10.1111/aji.13626. Epub 2022 Sep 28. Am J Reprod Immunol. 2022. PMID: 36121927 Free PMC article.

5

B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer.

Liu Z, Jin K, Zeng H, Shao F, Chang Y, Wang Y, Xu L, Wang Z, Cui X, Zhu Y, Xu J. Liu Z, et al. Eur J Cancer. 2022 Aug;171:133-142. doi: 10.1016/j.ejca.2022.05.022. Epub 2022 Jun 16. Eur J Cancer. 2022. PMID: 35717821

6

Silencing of B7H4 Represses the Development of Oral Squamous Cell Carcinoma Through Promotion of M1 Macrophage Polarization.

Chi J, Liu Y, Yang L, Yang J. Chi J, et al. J Oral Maxillofac Surg. 2022 Aug;80(8):1408-1423. doi: 10.1016/j.joms.2022.03.019. Epub 2022 Apr 15. J Oral Maxillofac Surg. 2022. PMID: 35568099

7

B7-H4 expression promotes non-small cell lung cancer progression via AMPK/mTOR signaling.

Li M, Che N, Feng Y, Liu X, Piao L, Xuan Y, Jin Y. Li M, et al. Exp Mol Pathol. 2022 Apr;125:104755. doi: 10.1016/j.yexmp.2022.104755. Epub 2022 Mar 10. Exp Mol Pathol. 2022. PMID: 35278461

8

B7 family member H4 induces epithelial-mesenchymal transition and promotes the proliferation, migration and invasion of colorectal cancer cells.

Yin Y, Shi L, Yang J, Wang H, Yang H, Wang Q. Yin Y, et al. Bioengineered. 2022 Jan;13(1):107-118. doi: 10.1080/21655979.2021.2009411. Bioengineered. 2022. PMID: 34818980 Free PMC article.

9

B7-H4 Expression in Precancerous Lesions of the Uterine Cervix.

Zhang Q, Zong L, Zhang H, Xie W, Yang F, Sun W, Cui B, Zhang Y. Zhang Q, et al. Biomed Res Int. 2021 Oct 5;2021:5857092. doi: 10.1155/2021/5857092. eCollection 2021. Biomed Res Int. 2021. PMID: 34651047 Free PMC article.

10

Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma.

Mizuno T, Kamai T, Tsuzuki T, Nishihara D, Kijima T, Arai K, Yoshida KI. Mizuno T, et al. Cancer Immunol Immunother. 2022 Mar;71(3):565-578. doi: 10.1007/s00262-021-03011-5. Epub 2021 Jul 18. Cancer Immunol Immunother. 2022. PMID: 34275008 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

171 results

Results by year